Technical analysis of Novo Nordisk A/S (NVO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease.
Price Performance
| 1 month | -0.05% |
| 3 months | -18.67% |
| Year-to-date | -24.74% |
| 1 year | -25.46% |
| 3 years | -60.28% |
| 5 years | -30.47% |
| 10 years | +115.48% |
52-Week Range
| 52-week High | $64.16 |
| 52-week Low | $35.12 |
| Avg Volume (90d) | 12.0M |
Technical Indicators
| SMA 50 | $41.50 |
| SMA 200 | $44.39 |
| Beta | 0.27 |
| 30-day Volatility (annualised) | 32.1% |
| Price vs SMA 50 | -7.7% |
| Price vs SMA 200 | -13.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $50.88 | |
| 2026-01 | $59.43 | +16.8% |
| 2026-02 | $37.45 | -37.0% |
| 2026-03 | $36.75 | -1.9% |
| 2026-04 | $42.22 | +14.9% |
| 2026-05 | $45.58 | +8.0% |
| 2026-06 | $47.94 | +5.2% |
| 2026-07 | $47.08 | -1.8% |
| 2026-07 | $47.08 | +0.0% |
| 2026-08 | $45.33 | -3.7% |
| 2026-09 | $37.91 | -16.4% |
| 2026-10 | $38.29 | +1.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-04 | $0.73 | $11.09B |
| 2026-08-05 | $0.82 | $10.89B |
| 2026-05-06 | $0.87 | $10.86B |
| 2026-02-03 | $0.90 | $12.13B |
| 2025-11-05 | $0.77 | $11.94B |
| 2025-08-06 | $0.93 | $11.92B |
| 2025-05-07 | $0.92 | $11.70B |
Price
| Price | $39.43 (closing price, October 28, 2026) |
| Market Cap | $174.6B |
| Exchange | NYSE |
| Country | DK |
Valuation Ratios
| P/E Ratio | 9.73 |
| Price / Book | 5.10 |
| EV / EBITDA | 6.88 |
| Dividend Yield | 4.59% |
Financial Health
| Debt / Equity | 0.63 |
| Current Ratio | 0.87 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 4.23 |